Patterns of resistance development with integrase inhibitors in HIV
Jean L Mbisa, Supang A Martin, Patricia A CaneVirus Reference Department, Microbiology Services, Health Protection Agency, London, UKAbstract: Raltegravir, the only integrase (IN) inhibitor approved for use in HIV therapy, has recently been licensed. Raltegravir inhibits HIV-1 replication by blockin...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2011-02-01
|
| Series: | Infection and Drug Resistance |
| Online Access: | http://www.dovepress.com/patterns-of-resistance-development-with-integrase-inhibitors-in-hiv-a6419 |